Valuation: BOIRON

Market Cap 332M 364M 307M 278M 521M 33.99B 545M 3.71B 1.47B 18.37B 1.37B 1.34B 58.19B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 284M 311M 263M 238M 446M 29.09B 467M 3.18B 1.26B 15.72B 1.17B 1.14B 49.79B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
12.84%
Yield 2024
4.48%
Yield 2025 4.46%
1 week+0.26%
Current month+2.14%
1 month+5.23%
3 months-27.10%
6 months-28.73%
Current year-36.96%
1 week 18.85
Extreme 18.85
19.25
1 month 17.45
Extreme 17.45
20.3
Current year 16.9
Extreme 16.9
30.95
1 year 16.9
Extreme 16.9
32.25
3 years 16.9
Extreme 16.9
42.8
5 years 16.9
Extreme 16.9
56.5
10 years 16.9
Extreme 16.9
92.7
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Date Insider Type Main position Quantity % Market Cap. Importance
10/29/23 A Sell

Director

198,664 1.1323%
10/29/23 A Sell

Director

462,964 2.6387%
10/29/23 A Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.26%-28.86%-52.06% 364M
-1.87%-5.01%+29.17%+126.86% 1,232B
-2.00%-5.78%+31.91%+78.19% 656B
-1.07%-3.92%+21.47%+104.55% 506B
-1.04%-1.80%+28.69%+68.33% 382B
-3.08%-8.87%+40.89%+30.42% 340B
-3.22%-5.20%+24.48%+50.97% 294B
-2.51%-4.49%-2.15%+31.64% 278B
-0.91%-5.76%+28.55%+65.87% 240B
-1.15%-0.60%+30.35%+119.66% 210B
Average -1.66%-2.15%+20.45%+62.44% 414B
Weighted average by Cap. -1.84%-2.67%+27.16%+87.38%

Financials

2024 2025
Net sales 488M 535M 451M 408M 766M 49.98B 802M 5.46B 2.16B 27.01B 2.01B 1.97B 85.55B 501M 550M 464M 420M 787M 51.37B 824M 5.61B 2.22B 27.76B 2.06B 2.02B 87.93B
Net income 11.34M 12.44M 10.49M 9.49M 17.81M 1.16B 18.64M 127M 50.32M 628M 46.68M 45.7M 1.99B 32.64M 35.83M 30.22M 27.33M 51.28M 3.35B 53.67M 365M 145M 1.81B 134M 132M 5.73B
Net Debt -49.74M -54.59M -46.04M -41.65M -78.13M -5.1B -81.77M -557M -221M -2.76B -205M -201M -8.73B -47.86M -52.52M -44.3M -40.07M -75.17M -4.91B -78.68M -535M -212M -2.65B -197M -193M -8.4B
Projected Income Statement - Annual - BOIRON
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change Volume
19/11/26 €19.10 0.00% 258
18/11/26 €19.10 -0.78% 649
17/11/26 €19.25 +1.32% 1,291
16/11/26 €19.00 -1.04% 1,591
13/11/26 €19.20 +0.79% 1,710

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BOIRON